Twist Bioscience Corporation: Leerink Partners raises target price to $190 from $160
TWST•Leerink Partners raised its target price for Twist Bioscience Corporation to $190 from $160.
Related News
One and One Green Technologies says H1 net income rises to USD 4.49 million
YDDL•
Atlas Critical Minerals defines 17.2 million-tonne indicated graphite resource in Brazil
ATCX•
Medicus Pharma submits Teverelix Phase 2b/3 registrational protocol to FDA for review
MDCX•
Medicus Pharma submits optimized teverelix protocol to FDA for advanced prostate cancer program
MDCX•
Italy to ask US energy secretary about potential diesel export ban, minister says
USO•